"Ben is another senior hire that reflects not just Reframe’s growth and strength, but its commitment to delivering the highest level of clinical excellence for cancer patients."
- Mark Stephenson, CEO of Reframe Cancer
Prior to this appointment, Prof. Ben Kelly (pictured) served as Data Director at Nuffield Health, previously Director of Research, Outcomes & Data Science, Head of Clinical Research & Outcomes, and Head of Preventative Medicine.
In the past, he’s also worked as Head of Interdisciplinary Medicine & Technology for the Medical Research Council, Research Fellow at King’s College London, and Research Associate at Harvard Medical School.
Commenting on his appointment, Ben said he’s "excited to join an organisation with such a strong purpose and focus.
"The opportunity to improve the quality of life of cancer patients is an honour and is something I’m motivated by and committed to. I aim to do all I can to support and positively contribute to the growth of this incredible organisation."
Mark Stephenson, CEO of Reframe Cancer, added: "We’re naturally thrilled that Ben has joined Reframe Cancer as Chief Operating Officer. His experience and clinical data expertise will facilitate Reframe Cancer in supporting even more patients as well as delivering industry-leading outcomes."
